The expression of TRP channels, such as transient receptor potential vanilloid 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1), in cells involved in detecting cancer pain and their role in pain-sensing makes them potential targets for pain relief compounds. The gene discussed is TRPV1; the disease is cancer.